Plante Moran Financial Advisors, LLC Puma Biotechnology, Inc. Transaction History

Plante Moran Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$41.2 - $59.85 $41,200 - $59,850	-1,000 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$48.3 - $68.25 $28,980 - $40,950	600 Added 150.0%	1,000 $59,000
Q1 2018 May 01, 2018	SELL	$59.7 - $99.25 $5,970 - $9,925	-100 Reduced 20.0%	400 $27,000
Q3 2017 Nov 08, 2017	BUY	$72.0 - $119.75 $36,000 - $59,875	500	500 $60,000

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.